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20—50 years) were enrolled in this study. All of the injec-
tion drug users were prisoners. Hepatitis B surface antigen
(HBsAg), hepatitis B surface antibody (anti-HBs), anti-HBc,
Anti-HIV and hepatitis C antibody (anti-HCV) were tested in
all subjects.
Results: Of the 531 blood donors, 11 subjects (2.1%) had
isolated anti-HBc and of 153 injection drug users, 12 cases
(7.84%) showed isolated anti-HBc. All of 12 injection drug
users with isolated anti-HBc were also HCV positive. Sero-
logic proﬁle of 2 groups was shown in Table 1.
Variable Blood donors Injection drug users P value
HBsAg 0.4% 7.2% 0
Anti-HBs 31.8% 43.8% 0
Anti-HBc 11.5% 35% 0
Anti-HCV 0.2% 59.5% 0
Anti-HIV 0% 5.9% 0
Conclusion: Our study showed that prevalence of isolated
anti-HBc among injection drug users was 3.73 fold in com-
parison with blood donors. This study supports that injection
drug use and incarceration is contributing to increase preva-
lence of isolated anti-HBc.
doi:10.1016/j.ijid.2010.02.1992
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Background: Health workers (HWs) have occupational
exposure to blood or body ﬂuids; unvaccinated HWs or those
vaccinated with low hepatitis-B surface antibodies‘‘(anti-
HBs) <10UI’’ are at higher risk of Hepatitis-B infection they
could be focus for dissemination of infection. Duration of
protection after fully vaccination is not known. The objec-
tive is to assess the immunogenicity ‘‘anti-HBs ‘‘10mIU/ml’’
post vaccination among HWs.
Methods: Two stage study; cross-sectional and follow-up
prospective-cohort. Voluntary HWs who met the inclusion
criteria were surveyed and tested primary for hepatitis-B
core antibodies and hepatitis-B surface antigen, only those
with negative results were tested for ‘‘anti-HBs’’; fully vac-
cinated HWs with negative anti-HBs were voluntary enrolled
in the second stage,retested for anti-HBs after 45 days from
a booster dose.
Results: 252 HWs participate in the study; 10% of those
don’t meet the inclusion criteria, primary study sample was
226 HWs, 81% were fully and 19% were partially vaccinated.
There was a signiﬁcant association between the number of
vaccine doses and the presence of anti-HBs, p-value-0.0002.
There is a signiﬁcant difference regarding the presence of
anti-HBs among fully or partially vaccinated HWs; P-value-
0.003. To verify ‘‘persistence’’, statistics were limited to
182 fully vaccinated HWs; was found signiﬁcant associa-
tion between the time period from the last administrated
doses, age at vaccination, duration of practice and the per-
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istence of antibodies, P-value-0.00004, 0.040, and 0.010
espectively. There were no signiﬁcant differences regard-
ng the vaccination site, Fisher exact: 0.7018. There is no
ssociation between the ‘‘place of working, profession, and
requency of exposure to blood or needle stick injury’’ and
he persistence of antibodies. 8% of participants in second
tage didn’t response by reforming the anti-HBs. 65% of
Ws who were exposed to a needle stick injury report no
ost exposure preventive measures was taken after they had
eported the injury.
Conclusion: The Hepatitis-B prevalence among HWs was
0%; the non-response rate to vaccine was 8%; the prob-
bility for antibodies-persistence is declining by time;
robability of antibodies persistence is highly signiﬁcant if
he period from the last administrated dose is less than three
ears and increases with a booster dose. The older age the
accine was administrated the higher was the risk to non
esponse to vaccine.
oi:10.1016/j.ijid.2010.02.1993
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egional and ethnical aspects of viral hepatitis B in preg-
ant women in Slovakia
. Kristian, I. Schreter, Z. Paralicova, P. Jarcuska ∗, L.
iegfried, S. Porubcin
Faculty of Medicine, University of P.J.Safarik, Kosice, Slo-
akia
Background: The estimated prevalence of HBsAg in Slo-
ak population is <2% with supposed regional differences
nd higher prevalence of HBV infection in Roma popula-
ion. Pregnant women constitute a special subgroup, that
s subject to routine HBsAg screening because of the risk
f vertical transmission, and also pregnancy can modify the
ourse of hepatitis B infection. The aim of this study was
o determine the prevalence of HBV infection in pregnant
omen in districts of eastern Slovakia with diverse preva-
ence of Roma population and to determine the subset of
omen with chronic hepatitis B and increased risk of vertical
ransmission.
Methods: We have analyzed data from 9 regional Depart-
ents of Clinical Microbiology from January 2008 till June
009. We have evaluated the portion of HBsAg positive ﬁnd-
ngs from the overall examined samples and among pregnant
omen. Available sera from HBsAg positive pregnant women
ere also screened for ALT, HBeAg and HBV DNA.
Results: Overall, 44,912 sera samples were examined,
ith 10,739 from pregnancy screening. The number of HBsAg
ositive samples overall and during pregnancy was 803
1.79%) and 251 (2.34%) respectively. Comparing districts
ith higher (>4%) and lower (<3%) prevalence of Roma popu-
ation, there was no notable difference in the overall HBsAg
revalence (1.85% vs. 1.68%), however in the subgroup of
regnant women (2.69% vs. 1.25%) this difference was highly
igniﬁcant (p < 0.001). HBV DNA was evaluated in 158 preg-
ant women, 19 patients had viral load >105 copies/ml, 27
n the range of 104-105 copies/ml and 112 patients < 104
r negative. HBeAg positivity was conﬁrmed in 17 of 146
xamined samples (11.6%) and elevated ALT in 11 of 69 cases
15.9%). Twelve out of 58 patients with normal ALT (21%) had
